Charity of the week: The Archaeological Conservancy
The Archaeological Conservancy is the only nonprofit of national reach dedicated to acquiring and preserving archaeological sites in the U.S.
The Archaeological Conservancy (americanarchaeology.com) is the only nonprofit of national reach dedicated to acquiring prehistoric and historic archaeological sites in the U.S. and preserving them for posterity. Important American archaeological sites are lost continually to suburban sprawl, agriculture, and looters using backhoes. Since 1980, the organization has acquired more than 400 sites in 41 states, including several containing some of the earliest evidence of human habitation in North America. The Conservancy’s preservation sites include California’s Borax Lake site, where humans have lived for over 11,000 years, and Fort Foster, Maine, site of the Revolutionary War’s first naval battle.
Each charity we feature has earned a four-star overall rating from Charity Navigator, which ranks not-for-profit organizations on the strength of their finances, their control of administrative and fund-raising expenses, and the transparency of their operations. Four stars is the group’s highest ranking.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
-
Extremists embrace Musk's salute as Tesla investors fret
IN THE SPOTLIGHT The tech titan insists his Nazi-reminiscent gesture had nothing to do with fascism, even as white nationalists rally around the fascistic salute.
By Rafi Schwartz, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Trump says 25% tariffs on Canada, Mexico start Feb. 1
Speed Read The tariffs imposed on America's neighbors could drive up US prices and invite retaliation
By Peter Weber, The Week US Published